BCBA/GSKD (BCBA/GSKD)

Buenos Aires Stock Exchange: BCBA/GSKD · USD

$12.9

-0.84 (-6.1%)· Recorded snapshot

Market cap	150.7T
Revenue (ttm)	67.9T
Net income (ttm)	8.8T
EPS (ttm)	$1,232
P/E (trailing)	16.1x
P/E (forward)	9.7x
Dividend	$605 (3.04%)
Volume	3

Market data

Price

Recent price action with selectable time range.

Financial snapshot

Revenue (ttm): 67.9T
Net income (ttm): 8.8T
EPS (ttm): $1,232
P/E (trailing): 16.1x
P/E (forward): 9.7x
Market cap: 150.7T

Calendar

Next earnings

Upcoming earnings date and setup when available.

Upcoming

DateLoading

Window—

EPS estimate—

Revenue estimate—

Sector percentile context

Refreshed 2026-10-29 13:30 UTC

Forward P/E9.7

P25 n/aP50 n/aP75 n/a

Trailing P/E16.1

P25 n/aP50 n/aP75 n/a

ROE28.3

P25 n/aP50 n/aP75 n/a

ROIC24.6

P25 n/aP50 n/aP75 n/a

Benchmarks · 1M

All BCBA/GSKD indicators

Market & fundamental data

Available fields

238

Groups with data

Currency

GBP

Showing 238 of 238 available metrics for this ticker.

Profile and market data

Ticker identity, listing, currency, market cap, and source dates.

Metric	Value
Amount currency	ARS
Country	United Kingdom
Country code	AR
Earnings date	2026-10-28
Employees	66,841
Employees change	-1,788
Employees growth	-2.61%
Enterprise value	$192.5T
Exchange	Buenos Aires Stock Exchange
Financial currency	GBP
Financial report date	2026-09-30
First seen	2026-08-25
Fiscal year end	December
Founded	1715
Industry	Drug Manufacturers - General
Is primary listing	No
ISIN number	ARDEUT110483
Last earnings date	2026-10-28
Last refreshed	2026-10-29
Last stock split date	2022-07-22
Last stock split type	Reverse
Market cap	$150.7T
Next earnings date	2027-02-03
Price	$12.88
Price currency	USD
Sector	Healthcare
SIC code	2834
Stock price date	2026-10-28
Symbol	bcba/GSKD
Website	https://www.gsk.com

Valuation

Multiples, yields, enterprise-value ratios, and valuation checks.

Metric	Value
Average P/E ratio (10Y)	21.56x
Average P/E ratio (3Y)	16.33x
Average P/E ratio (5Y)	13.77x
Earnings yield	6.2%
EV/Earnings	21.81x
EV/FCF	12.79x
FCF / EV yield	7.82%
FCF yield	10%
Forward P/E	9.73x
Graham number	7.83733
Graham upside	-42.88%
Lynch fair value	$4.02
Lynch upside	-70.69%
P/(FCF - SBC) ratio	10.53x
P/(OCF - SBC) ratio	8.69x
P/B ratio	4.04x
P/E ratio	16.12x
P/FCF ratio	10x
P/OCF ratio	8.32x
P/S ratio	2.21x
Price/EBITDA ratio	6.7x

Profitability

Margins, returns on capital, cash conversion, and quality metrics.

Metric	Value
EBIT margin	29.31%
EBITDA margin	33.02%
Effective tax rate	10.42%
FCF margin	21.83%
Gross margin	73.79%
Operating margin	29.31%
Pretax margin	16.05%
Profit margin	12.97%
Profit per employee	$131.8M
Profitable quarters	8
Profitable years	41
Revenue per employee	$1B
ROA	9.24%
ROA (5Y)	7.23%
ROCE	19.28%
ROE	28.27%
ROE (5Y)	32.1%
ROIC	24.61%
ROIC (5Y)	22.54%
SBC / revenue	1.11%
Tax / revenue	1.67%

Growth

Revenue, earnings, cash-flow, and forward growth indicators.

Metric	Value
EPS growth	-19.72%
EPS growth (Q)	-22.81%
EPS growth (QoQ)	254.21%
EPS growth 10Y	30.09%
EPS growth 3Y	-10.33%
EPS growth 5Y	0%
EPS growth years	1
FCF growth	14.66%
FCF growth (Q)	27.42%
FCF growth (QoQ)	3.09%
FCF growth 3Y	20.79%
FCF growth 5Y	1.32%
Gross profit growth	6.23%
Gross profit growth (Q)	5.53%
Gross profit growth 3Y	5.77%
Gross profit growth 5Y	6.43%
Net income growth	-20.81%
Net income growth (Q)	-23.35%
Net income growth (QoQ)	254.71%
Net income growth 3Y	-10.52%
Net income growth 5Y	0.18%
Net income growth years	1
OCF growth	14.45%
OCF growth (Q)	26.42%
OCF growth (QoQ)	4.42%
OCF growth 10Y	5.94%
OCF growth 3Y	17.65%
OCF growth 5Y	2.09%
Operating income growth	11.46%
Operating income growth (Q)	-7.33%
Operating income growth 3Y	8.97%
Operating income growth 5Y	8.44%
Revenue growth	4.28%
Revenue growth (Q)	3.98%
Revenue growth (QoQ)	5.68%
Revenue growth 10Y	2.35%
Revenue growth 3Y	4.2%
Revenue growth 5Y	4.94%
Revenue growth quarters	8
Revenue growth years	4

Financial statements

Income-statement and cash-flow amounts, totals and per share.

Metric	Value
Capital expenditures	$-3T
Depreciation and amortization	$2.6T
EBIT	$19.9T
EBITDA	$22.4T
EPS	$1,231.99
Financing cash flow	$3.9T
Free cash flow	$15T
Free cash flow minus SBC	$14.3T
Gross profit	$50.1T
Income taxes	$1.1T
Investing cash flow	$-22.1T
Net borrowing	$12.9T
Net cash flow	$-157.9B
Net income	$8.8T
Operating cash flow minus SBC	$17.3T
Operating income	$19.9T
Revenue	$67.9T
Stock-based compensation	$757.2B

Financial strength

Debt, cash, solvency, accounting-quality, and balance-sheet signals.

Metric	Value
Altman Z-Score	1.98
Book value per share	$9,470.47
Debt / EBITDA	2.11
Debt / equity	1.3
Debt / FCF	3.21
Goodwill	$16.9T
Interest coverage	14.94
Long-term assets	$108.4T
Long-term liabilities	$65.5T
Net cash (debt)	$-42.2T
Net cash / market cap	-28.08%
Net debt / EBITDA	1.88
Net debt / equity	1.13
Net debt / FCF	2.81
Piotroski F-Score	6
Property, plant and equipment	$20.8T
Shareholders' equity	$37.2T
Tangible book value	$-29.6T
Tangible book value per share	$-7,389.94
Total assets	$145.2T
Total cash	$6T
Total debt	$48.2T
Total liabilities	$108T

Liquidity

Current-asset coverage and working-capital efficiency metrics.

Metric	Value
Asset turnover	0.5
Current assets	$36.7T
Current liabilities	$42.5T
Current ratio	0.86
Inventory turnover	1.42
Net working capital	$-7.7T
Quick ratio	0.55
Working capital	$-5.7T
Working capital turnover	-21,499.82

Dividends and buybacks

Dividend yield, payout, buybacks, and shareholder-yield indicators.

Metric	Value
Buyback yield / dilution	1.37%
Dividend growth	10.29%
Dividend growth (3Y)	8.07%
Dividend growth years	3
Dividend payment date	2026-10-08
Dividend payment years	6
Dividend payout frequency	Quarterly
Dividend per share	$604.66
Dividend yield	3.05%
Ex-dividend date	2026-08-14
Last dividend	$0.10
Payout ratio	62.01%
Shareholder yield	4.23%

Performance and technicals

Returns, volatility, beta, momentum, RSI, and moving-average context.

Metric	Value
150-day SMA	$13.29
1D price change	-6.12%
1M price change	5.38%
1M total return	5.38%
1W price change	5.3%
1W total return	5.3%
1Y price change	22.94%
1Y return CAGR	26.82%
1Y total return	26.8%
20-day SMA	$12.75
200-day SMA	$12.38
3M price change	3.55%
3M total return	4.44%
3Y price change	37.2%
3Y return CAGR	14.94%
3Y total return	51.86%
50-day SMA	$13.05
50-day SMA vs 200-day SMA	50over200
52-week high	$15.96
52-week high date	2026-02-18
52-week low	$11.00
52-week low date	2025-11-14
5Y price change	33.2%
5Y return CAGR	13.65%
5Y total return	89.59%
6M price change	-3.85%
6M total return	-2.28%
All-time high	$15.96
All-time high date	2026-02-18
All-time low	$8.15
All-time low date	2025-01-14
Average true range (ATR)	$0.23
Average volume	119.6
Change from 52-week high	-19.3%
Change from 52-week low	17.09%
Change from all-time high	-14.04%
Change from all-time low	68.34%
Change from open	-1.53%
Day's gap	-4.66%
Dollar volume	$38.64
High price	$13.08
Low price	$12.88
Monthly RSI	60.54
Open price	$13.08
Position in 52-week range	0%
Previous close	$13.72
Price vs 150-day SMA	3.27%
Price vs 20-day SMA	7.63%
Price vs 200-day SMA	10.86%
Price vs 50-day SMA	5.17%
Relative volume	0.03
RSI	64.67
Sharpe ratio	0.86
Sortino ratio	1.35
Volume	3
Weekly RSI	55.21
YTD price change	8.46%
YTD total return	10.99%

Ownership and float

Institutional, insider, float, short-interest, and share-count fields.

Metric	Value
Float	3.9B
Shares change (QoQ)	0.27%
Shares change (YoY)	-1.37%
Shares held by insiders	0.06%
Shares held by institutions	84.53%

Deeper analysis on BCBA/GSKD

14 sections in the full report · jump straight to what you need

Forecast

Base and Bull forecast paths with report-date return framing.

→

Valuation

Fair-value bridge, DCF, owner earnings, and peer multiples.

→

Sensitivity

Cost-of-equity and terminal-growth stress table.

→

Risks

Kill scenarios, soft-pass flags, and downside catalysts.

→

Earnings

Next earnings setup and beat / inline / miss thresholds.

→

Position sizing

Entry, exit, conviction, and quarterly monitoring rules.

→

Financials

Revenue, margins, cash flow, and balance-sheet context.

→

Peers

Relative valuation and profitability against the cohort.

→

Moat

Economic-profit evidence and competitive advantage risk.

→

Industry cycle

Sector phase, capital cycle, and secular tailwinds.

→

Frequently asked questions

About this BCBA/GSKD report

Is a complete BCBA/GSKD research report available?

No complete published report is available for bcba/GSKD (BCBA/GSKD) on this page. Market-directory data, when present, is not a substitute for a validated stock analysis.

BCBA/GSKD (BCBA/GSKD)

Price

Financial snapshot

Fair-value bridge

Latest news · BCBA/GSKD

Valuation

Profitability

Balance sheet

Trading

Next earnings

Sector percentile context

All BCBA/GSKD indicators

Profile and market data

Valuation

Profitability

Growth

Financial statements

Financial strength

Liquidity

Dividends and buybacks

Performance and technicals

Ownership and float

Deeper analysis on BCBA/GSKD

Frequently asked questions